Guanfacine extended-release (Intuniv® and generic) is a central alpha 2a receptor agonist that is FDA-approved as a treatment for ADHD both as: – Monotherapy and – As an adjunct to a stimulant medication. The Prescribing Information for guanfacine extended-release notes that its efficacy in the treatment of ADHD was established in children and adolescents 6…
This content is for Monthly Membership and Yearly Membership members only.
Register
Register
Already a member? Log in here